Diagnosis and morbidity of placenta accreta

Ultrasound Obstet Gynecol. 2011 Mar;37(3):324-7. doi: 10.1002/uog.8827. Epub 2011 Feb 8.


Objective: To examine the diagnostic precision of ultrasound examination for placenta accreta in women with placenta previa and to compare the morbidity associated with accreta to that of previa alone.

Methods: This was a retrospective cohort study of all women with previa with/without accreta examined at the University of California, San Francisco (UCSF) between 2002 and 2008. The sensitivity, specificity, negative predictive value (NPV) and positive predictive value (PPV) of ultrasound examination for the diagnosis of accreta were calculated and compared with results from similar studies in the literature. Univariable analysis was used to compare clinical outcomes.

Results: The PPV of an ultrasound diagnosis of accreta was 68% and NPV was 98%. Ultrasound had a sensitivity of 89.5%. Compared with previa alone, accreta had an odds ratio (OR) of 89.6 (95% CI, 19.44-412.95) for estimated blood loss > 2 L, an OR of 29.6 (95% CI, 8.20-107.00) for transfusion and an OR of 8.52 (95% CI, 2.58-28.11) for length of hospital stay > 4 days.

Conclusion: Placenta accreta is associated with greater morbidity than is placenta previa alone. Ultrasound examination is a good diagnostic test for accreta in women with placenta previa. This is consistent with most other studies in the literature.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cesarean Section, Repeat / adverse effects*
  • Cohort Studies
  • Female
  • Humans
  • Hysterectomy
  • Placenta Accreta / diagnostic imaging*
  • Placenta Accreta / etiology
  • Placenta Previa / diagnostic imaging*
  • Placenta Previa / etiology
  • Postpartum Hemorrhage / diagnostic imaging*
  • Postpartum Hemorrhage / etiology
  • Predictive Value of Tests
  • Pregnancy
  • Retrospective Studies
  • Risk Factors
  • San Francisco
  • Sensitivity and Specificity
  • Ultrasonography, Prenatal / methods